✓ Enriched with full company details from live data.
IndustryPharmaceutical Manufacturing
Employees1-10
HeadquartersAtlanta, Georgia, United States
Funding stageOther
Total funding$184.6M
LinkedIn followers2
Est. revenue$260.5K
Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson's disease and drive functional reversal inside and outside of the
Technology stack
Click any tool to see other companies using it.
AIAmazon AWSApacheCircleGoogle AdSenseGoogle AnalyticsGoogle Font APIGoogle Tag ManagerMicrosoft Office 365Mobile FriendlyOutlookProofpointRemoteRoute 53YouTube
🔥 19 people from Inhibikase Therapeutics, Inc. are searchable on evyAI — names, titles, and unlockable contact info.